What decision was AI permitted to make or shape?
Was AI informing, recommending, ranking, initiating, approving, denying, or executing?
Prior authorization decision control
Why was AI allowed to make or materially shape this coverage decision?
A model score or reviewer signature is not enough. The organization must be able to reconstruct the evidence, AI’s role, the authority that applied, and why the action was permitted.
The defensibility test
Five questions have to be answered together.
Start with why AI was allowed to shape the determination. Then test whether the evidence, competence, review, and final action justified that authority.
Was the evidence sufficient for this case?
What was present, missing, current, relevant, and available to the reviewer?
Was the case within demonstrated competence?
Did the case resemble conditions under which the system had been evaluated, or was it novel?
Was human review meaningful?
Could the reviewer see the evidence, disagree, change the action, and own the consequence?
Why did this action proceed?
Why was approval, denial, evidence request, escalation, or hold justified at that moment?
A coverage decision in motion
High confidence does not authorize the workflow to act.
The case can change after submission. Evidence can conflict. A recommendation can remain confident even when a prerequisite is missing. Decision control changes the permitted action when the case state changes.
CMS-0057-F
CMS-0057-F shapes the operating environment. The defensibility question remains case-specific.
The defensibility question is separate: can the organization reconstruct why this particular determination was allowed to proceed?
Buyer questions
Questions behind a defensible coverage determination.
The organization must be able to reconstruct evidence, authority, review, and action.
Why is AI-influenced prior authorization a defensibility problem?
The organization may need to explain why AI was allowed to influence a particular review, recommendation, approval, or denial. That requires visibility into individualized review, the evidence available, the authority exercised, and whether the decision state can be reconstructed later.
How does CMS-0057-F appear in GNS-AI’s prior authorization work?
CMS-0057-F is part of the operating context for prior authorization. GNS-AI focuses on a separate decision-level issue: whether an organization can reconstruct the evidence, individualized review, AI influence, and authority behind a particular determination. Responsible legal and compliance teams determine how the rule applies.
Does GNS-AI automate clinical judgment?
The objective is not to hide or replace qualified judgment. GNS-AI helps the workflow move evidence-supported cases, identify what remains unresolved, make authority explicit, and route cases to the right human when the decision should not proceed automatically.
Start with the current decision
Choose the prior-authorization decision that must improve.
Use a Blueprint to design the workflow, Production Assurance to test an existing vendor or pilot, or a DCP Shadow Pilot when AI already influences live determinations.
Commercial entry points: AI Decision System Working Session, AI Decision System Blueprint, Production Assurance, or DCP Shadow Pilot.